Full Text View
Tabular View
No Study Results Posted
Related Studies
Study to Determine the Effectiveness of Pillar Palatal Implants to Treat Obstructive Sleep Apnea
This study has been completed.
Study NCT00307957   Information provided by University of Cincinnati
First Received: March 27, 2006   Last Updated: December 10, 2007   History of Changes

March 27, 2006
December 10, 2007
October 2005
 
  • Daytime Sleepiness (ESS)
  • Apnea/Hypopnea Index (AHI)
Same as current
Complete list of historical versions of study NCT00307957 on ClinicalTrials.gov Archive Site
  • Sleep Related Quality of Life (FOSQ)
  • Reaction Time Testing (PVT)
  • Other polysomnographic parameters (AI, HI, RERArl, Arl, LSat)
Same as current
 
Study to Determine the Effectiveness of Pillar Palatal Implants to Treat Obstructive Sleep Apnea
Pillar Palatal Implant System Multi-Institutional, Randomized Placebo-Controlled Study for Obstructive Sleep Apnea

The Pillar palatal implant procedure is a minimally invasive and commercially available treatment for mild to moderate obstructive sleep apnea (OSA) in the United States and Europe. The implants are placed into the soft area in the roof of the mouth providing support to the soft palate. This research is being done to compare daytime sleepiness and sleep related quality of life after palatal implants.

Patients will be enrolled into the study based on sleep study results, a physical exam and inclusion/exclusion criteria. Once enrolled, patients are randomized into either the Pillar palatal implant group or a placebo/sham group.

In both cases, patients come into the office for placement of the implants. This is an outpatient procedure. Patients are followed at one week, one month and 3 months. At each follow-up visit, patients will undergo a physical exam and complete questionnaires related to sleep and quality of life. Patients will also undergo reaction time testing on hand-held device similar to a pocket video game. At the three month visit, patients will return to the sleep lab for another sleep study.

Phase IV
Interventional
Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Obstructive Sleep Apnea
Device: Pillar Palatal Implants
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
100
October 2006
 

Inclusion Criteria:

  • 18 years or older
  • Body Mass Index equal to 32 or less
  • Apnea-Hypopnea Index greater than/equal to 10 and less than/equal to 30
  • Symptoms of daytime sleepiness

Exclusion Criteria:

  • Septal deviation or nasal obstruction
  • Nasal polyps
  • Severe seasonal allergies
  • Soft palate length insufficient to accommodate implants
  • Fujita Modified Mallampati Class 3
  • Large tonsils
  • Lingual tonsil hypertrophy
  • Hypopharyngeal obstruction
  • Previous pharyngeal surgery
  • Previous upper respiratory tract cancer or radiation therapy
  • Active respiratory tract infection
  • Dysphagia or speech disorder
  • Neurologic disorder
  • Unstable psychiatric disorder
  • Pregnant or breastfeeding
  • History of falling asleep driving or MVA due to sleepiness
  • Currently on CPAP therapy or other device for OSA
  • Other sleep disorders
Both
18 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00307957
 
05-08-14-1
University of Cincinnati
Medtronic Xomed, Inc.
Principal Investigator: David L Steward, MD University Ear, Nose and Throat Specialists
University of Cincinnati
December 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP